Last reviewed · How we verify
OMACOR (OMEGA-3ACID ETHYL ESTERS)
OMACOR (generic name: OMEGA-3ACID ETHYL ESTERS) is a drug developed by RELIANT PHARMS. It is currently FDA-approved.
At a glance
| Generic name | OMEGA-3ACID ETHYL ESTERS |
|---|---|
| Sponsor | RELIANT PHARMS |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- OMEGA: A Prospective, Randomised, Double-Blind, Placebo-Controlled Multicentre Study in Patients Who Survived Acute Myocardial Infarction to Investigate the Efficacy and Safety of 1 Gram Ω-3-Fatty Aci (Phase 3)
- "Go Fish"Omega-3 Fatty Acid Supplementation in Diabetic Kidney Disease (Phase 3)
- Lovaza Therapy of Peripheral Arterial Disease (NA)
- Effects of a Prescription Omega-3 Fatty Acid Concentrate in a Placebo-controlled Trial of Human Endotoxemia (NA)
- Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease (Phase 4)
- OM6X: An Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Combined Lovaza (Previously Omacor®) and Simvastatin Therapy in Hypertriglyce (Phase 3)
- Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial (Phase 4)
- A Two-cohort, Single-sequence, Parallel, Open Label, Multiple Oral Dosing Phase I Study to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Omega-3 and Atorvastatin in Healthy Male (Phase 1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- OMACOR CI brief — competitive landscape report
- OMACOR updates RSS · CI watch RSS
- RELIANT PHARMS portfolio CI
Frequently asked questions about OMACOR
What is OMACOR?
OMACOR (OMEGA-3ACID ETHYL ESTERS) is a pharmaceutical drug developed by RELIANT PHARMS.
Who makes OMACOR?
OMACOR is developed and marketed by RELIANT PHARMS (see full RELIANT PHARMS pipeline at /company/reliant-pharms).
What is the generic name of OMACOR?
OMEGA-3ACID ETHYL ESTERS is the generic (nonproprietary) name of OMACOR.
What development phase is OMACOR in?
OMACOR is FDA-approved (marketed).
Related
- Manufacturer: RELIANT PHARMS — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing